Adarza BioSystems Receives $5,000,000 Series B Funding

  • Feed Type
  • Date
    3/22/2016
  • Company Name
    Adarza BioSystems
  • Mailing Address
    150 Lucius Gordon Drive West Henrietta, NY 14586 USA
  • Company Description
    Adarza BioSystems develops a biological assay platform for measuring clinical and point-of-care samples.
  • Website
    http://www.adarzabio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from the financing will be used to expand production capacity in its St. Peters, MO manufacturing facility and launch its first immunoassay product consumable and instrument platform. Proceeds will also be used to accelerate development of highly sensitive assays targeting a variety of biological analytes including cytokines, antigens and small molecules.
  • M&A Terms
  • Venture Investor
    Cultivation Capital
  • Venture Investor
    Lewis & Clark Ventures
  • Venture Investor
    Siemens Venture Capital

Trending on Xconomy